AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

AstroNova, Inc.

Regulatory Filings Mar 5, 2010

Preview not available for this file type.

Download Source File

8-K 1 form8k342010.htm FORM 8-K form8k342010.htm Licensed to: HAS Document Created using EDGARizer 5.1.5.0 Copyright 1995 - 2009 Thomson Reuters. All rights reserved.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 8-K


CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT

(DATE OF EARLIEST EVENT REPORTED)

March 4, 2010


ASTRO-MED, INC

(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)


COMMISSION FILE NUMBER 0-13200

| RHODE
ISLAND | 05-0318215 |
| --- | --- |
| (STATE OR
OTHER JURISDICTION OF INCORPORATION OR
ORGANIZATION) | (IRS
EMPLOYER IDENTIFICATION NUMBER) |

600 EAST GREENWICH AVENUE, WEST WARWICK, RI 02893

(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES, INCLUDING ZIP CODE)

(401-828-4000)

(REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE)

ITEM 5.02. COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

On March 4, 2010, Astro-Med, Inc. (the “Company”) purchased certain stock options of the Company held by Everett V. Pizzuti, President and Chief Operating Officer of the Company, and Joseph P. O’Connell, Senior Vice President, Treasurer and Chief Financial Officer of the Company. The options entitled Mr. Pizzuti to purchase up to 103,125 shares of the Company’s common stock and Mr. O’Connell to purchase up to 68,750 shares of the Company’s common stock. The options had an exercise price of $5.4546 and were due to expire on March 20, 2010. The purchase price paid for the options was $131,732 to Mr. Pizzuti and $87,821 to Mr. O’Connell, representing the closing price for the Company’s common stock on March 3, 2010 less a 10% discount less the exercise price for each of the Options.

The purchase of the options as described above was reviewed and approved by the Company’s Compensation and Audit Committees.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

(c) Exhibit

Exhibit no. Exhibit

None.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized.

| /s/
Joseph P. O'Connell |
| --- |
| Joseph
P. O'Connell |
| Senior
Vice President, Treasurer and Chief Financial Officer |

Talk to a Data Expert

Have a question? We'll get back to you promptly.